文献速递药物不良反应与药物警戒特殊人群用药

NMDAR拮抗剂与药物滥用及依赖关联的WHO药物警戒数据库不成比例分析

Association between NMDAR antagonists, drug abuse and dependence: A disproportionality analysis from the WHO pharmacovigilance database.
PubMed 文献 · Br J Clin Pharmacol · 2022-06-14

所有药物均显示显著关联,提示可能存在类效应,需进一步研究,医务人员应警惕其滥用潜力。

要点

  • 右美沙芬、氯胺酮、金刚烷胺和美金刚均与药物滥用/依赖报告显著关联。
  • 右美沙芬IC=3.03[2.97-3.09],氯胺酮IC=1.70[1.57-1.83],信号较强。
  • 金刚烷胺IC=0.21[0.06-0.35]和美金刚IC=0.27[0.13-0.40]信号较弱但显著。

核心结论

  • 所有研究的NMDAR拮抗剂均与药物滥用和依赖报告显著关联,提示类效应。

主要发现

  • 右美沙芬IC=3.03[2.97-3.09],氯胺酮IC=1.70[1.57-1.83],金刚烷胺IC=0.21[0.06-0.35],美金刚IC=0.27[0.13-0.40]。
  • 所有 investigated drugs 均显示显著关联。

临床怎么用

  • 医务人员应警惕NMDAR拮抗剂的滥用潜力,尤其在当前阿片类药物流行背景下作为非阿片类镇痛药使用增多。

局限性

  • 该信号需进一步研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ketamine and dextromethorphan are widely abused psychoactive substances. Inhibition of N-methyl-d-aspartate receptors (NMDARs) results in neurobehavioural effects including hallucinations, "out of body" sensations and dissociative effects. However, little is known about a possible extended addictive class effect linked to pharmacologically-related amino-adamantane derivatives (e.g., amantadine and memantine). Using a quasi-Bayesian analytic method, we investigated the potential association between the use of approved NMDAR antagonists (i.e., dextromethorphan, ketamine, amantadine and memantine) and the reporting of drug abuse and dependence in the WHO pharmacovigilance database (VigiBase®), which includes >21 million individual case safety reports collected from >130 countries. This disproportionality analysis identified a significant association for all investigated drugs: dextromethorphan (IC = 3.03 [2.97-3.09]), ketamine (IC = 1.70 [1.57-1.83]), amantadine (IC = 0.21 [0.06-0.35]) and memantine (IC = 0.27 [0.13-0.40]), suggesting a class effect for drug abuse and dependence. This first signal requires further investigations, but health professionals need to be alert to the potential of abuse of NMDAR antagonists, especially in the current "opioid epidemic" context, due to their growing interest as non-opioid antinociceptive drugs.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Revol B, Lapeyre-Mestre M, Fouilhé Sam-Laï N, et al. Association between NMDAR antagonists, drug abuse and dependence: A disproportionality analysis from the WHO pharmacovigilance database. Br J Clin Pharmacol. 2022. PMID: 35665950. doi:10.1111/bcp.15430

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。